Stock Events

Stock Events

Evotec 

$3.2
369
+$0.08+2.56% Tuesday 20:00

Statistics

Day High
3.2
Day Low
3.11
52W High
4.73
52W Low
2.31
Volume
31,301
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jan 19
$0.02
Dec 18
$0.01
Nov 18
$0.01
Oct 18
$0.01
Sep 18
$0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

8AprExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
-0.58
-0.1
0.39
0.87
Expected EPS
0.02
Actual EPS
0.052

Financials

-24.6%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
855.39MRevenue
-210.46MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EVO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap4.98B
CRISPR Therapeutics is involved in gene editing, a field that overlaps with Evotec's drug discovery platforms, making them direct competitors in the biotech innovation space.
Vertex Pharmaceuticals
VRTX
Mkt Cap107.83B
Vertex Pharmaceuticals focuses on creating new treatments for serious diseases, directly competing with Evotec's drug discovery and development services.
Novartis
NVS
Mkt Cap279.67B
Novartis is a large pharmaceutical company that competes with Evotec in the drug discovery and development sector, particularly in the development of novel therapeutics.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences is a biopharmaceutical company that competes with Evotec in the area of drug discovery, development, and commercialization, especially in the fields of antiviral drugs.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biotechnology firm focusing on human therapeutics, competing with Evotec in drug discovery and development, particularly in the biotech sector.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals is known for its innovation in biopharmaceuticals, competing with Evotec in drug discovery and development, especially in the area of monoclonal antibodies.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical focuses on enzyme replacement therapies and rare genetic diseases, competing with Evotec in the niche market of rare diseases drug discovery.
Alnylam Pharmaceuticals
ALNY
Mkt Cap39.51B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, competing with Evotec in the development of novel RNA-based therapies.
Beam Therapeutics
BEAM
Mkt Cap3.15B
Beam Therapeutics competes with Evotec in the cutting-edge field of gene editing, specifically using base editing technology to develop precision genetic medicines.

About

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
Show more...
CEO
Dr. Christian Wojczewski Ph.D.
Employees
4766
Country
Germany
ISIN
US30050E1055

Listings

MU
DE
EVT.MU
STU
DE
EVT.STU
STU
DE
EVTA.STU
MU
DE
EVTA.MU

0 Comments

Share your thoughts

FAQ

What is Evotec stock price today?▼
The current price of EVO is $3.2 USD — it has increased by +2.56% in the past 24 hours. Watch Evotec stock price performance more closely on the chart.
What is Evotec stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Evotec stocks are traded under the ticker EVO.
Is Evotec stock price growing?▼
EVO stock has risen by +8.84% compared to the previous week, the month change is a +22.14% rise, over the last year Evotec has showed a -20.99% decrease.
What were Evotec earnings last quarter?▼
EVO earnings for the last quarter are 0.05 USD per share, whereas the estimation was 0.02 USD resulting in a +160% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Evotec revenue for the last year?▼
Evotec revenue for the last year amounts to 855.39M USD.
What is Evotec net income for the last year?▼
EVO net income for the last year is -210.46M USD.
Does Evotec pay dividends?▼
Yes, EVO dividends are paid monthly. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Evotec have?▼
As of May 06, 2026, the company has 4,766 employees.
In which sector is Evotec located?▼
Evotec operates in the Health & Wellness sector.
When did Evotec complete a stock split?▼
The last stock split for Evotec was on October 20, 2021 with a ratio of 4:1.
Where is Evotec headquartered?▼
Evotec is headquartered in Hamburg, Germany.